Universal Health (0LJL) Share Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0LJL Analyst Ratings

Hold

4 Buy

8 Hold

1 Sell

Based on 13 analysts giving stock ratings to

Universal

Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0LJL Stock 12 Month Forecast

Average Price Target

$192.62

▲(12.08% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Universal Health in the last 3 months. The average price target is $192.62 with a high forecast of $290.00 and a low forecast of $166.00. The average price target represents a 12.08% change from the last price of $171.86.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"144":"$144","291":"$291","180.75":"$180.8","217.5":"$217.5","254.25":"$254.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":290,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$290.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":192.6153846153846,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$192.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":166,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$166.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[144,180.75,217.5,254.25,291],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,171.86,180.9476923076923,190.03538461538463,199.12307692307692,208.21076923076924,217.29846153846154,226.38615384615383,235.47384615384615,244.56153846153848,253.64923076923077,262.73692307692306,271.8246153846154,280.91230769230765,{"y":290,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,171.86,173.4565680473373,175.05313609467456,176.64970414201184,178.24627218934913,179.84284023668638,181.43940828402367,183.03597633136096,184.63254437869824,186.2291124260355,187.82568047337278,189.42224852071007,191.01881656804733,{"y":192.6153846153846,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,171.86,171.4092307692308,170.95846153846156,170.5076923076923,170.05692307692308,169.60615384615386,169.15538461538463,168.70461538461538,168.25384615384615,167.80307692307693,167.3523076923077,166.90153846153845,166.45076923076923,{"y":166,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":180.742,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":200.078,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":216.133,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":243.313,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":218.546,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":200.56,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":205.532,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":178.312,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":166.143,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.337,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":150.285,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":167.025,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":171.86,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$290.00

Average Price Target$192.62

Lowest Price Target$166.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Stephen Baxter

Wells Fargo

$166

Hold

-3.41%

Downside

Reiterated

09/08/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Surrozen (NASDAQ: SRZN), Liquidia Technologies (NASDAQ: LQDA) and Universal Health (NYSE: UHS)

Benjamin Rossi

J.P. Morgan

$200

Hold

16.37%

Upside

Reiterated

09/03/26

J.P. Morgan Keeps Their Hold Rating on Universal Health (UHS)

A.J. Rice

UBS

$290

Buy

68.74%

Upside

Assigned

08/31/26

UBS Reaffirms Their Buy Rating on Universal Health (UHS)

Ben Hendrix

RBC Capital

$183

Hold

6.48%

Upside

Reiterated

08/19/26

RBC Capital Sticks to Its Hold Rating for Universal Health (UHS)

Kevin Fischbeck

Bank of America Securities

$162→$170

Sell

-1.08%

Downside

Reiterated

08/10/26

Bank of America Securities Sticks to Their Sell Rating for Universal Health (UHS)

Scott Fidel

Goldman Sachs

$242→$190

Hold

10.56%

Upside

Assigned

07/30/26

Universal Health price target lowered to $190 from $242 at Goldman SachsUniversal Health price target lowered to $190 from $242 at Goldman Sachs

Craig Hettenbach

Morgan Stanley

$212→$191

Hold

11.14%

Upside

Reiterated

07/29/26

Analysts Conflicted on These Healthcare Names: Haemonetics (NYSE: HAE), Arrowhead Pharmaceuticals (NASDAQ: ARWR) and Universal Health (NYSE: UHS)

Ryan Langston

TD Cowen

$197

Buy

14.63%

Upside

Assigned

07/29/26

TD Cowen Reaffirms Their Buy Rating on Universal Health (UHS)

Michael Ha

Robert W. Baird

$204→$166

Hold

-3.41%

Downside

Reiterated

07/29/26

Universal Health price target lowered to $166 from $204 at BairdUniversal Health price target lowered to $166 from $204 at Baird

Sarah James

Cantor Fitzgerald

$194

Hold

12.88%

Upside

Reiterated

07/28/26

Analysts Offer Insights on Healthcare Companies: Universal Health (NYSE: UHS), Insmed (NASDAQ: INSM) and Edwards Lifesciences (NYSE: EW)

Jason Cassorla

Guggenheim

$195→$189

Buy

9.97%

Upside

Reiterated

07/28/26

Analysts Are Bullish on These Healthcare Stocks: Universal Health (UHS), Incyte (INCY)

Andrew Mok CFA

Barclays

$179→$168

Hold

-2.25%

Downside

Reiterated

07/28/26

Barclays Sticks to Its Hold Rating for Universal Health (UHS)

Ann Hynes

Mizuho Securities

$230→$200

Buy

16.37%

Upside

Reiterated

07/13/26

Mizuho Securities Sticks to Their Buy Rating for Universal Health (UHS)

John Ransom

Raymond James

―

Hold

―

Downgraded

04/29/26

Universal Health downgraded to Market Perform from Outperform at Raymond JamesUniversal Health downgraded to Market Perform from Outperform at Raymond James

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

10/28/25

KeyBanc Remains a Hold on Universal Health (UHS)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Stephen Baxter

Wells Fargo

$166

Hold

-3.41%

Downside

Reiterated

09/08/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Surrozen (NASDAQ: SRZN), Liquidia Technologies (NASDAQ: LQDA) and Universal Health (NYSE: UHS)

Benjamin Rossi

J.P. Morgan

$200

Hold

16.37%

Upside

Reiterated

09/03/26

J.P. Morgan Keeps Their Hold Rating on Universal Health (UHS)

A.J. Rice

UBS

$290

Buy

68.74%

Upside

Assigned

08/31/26

UBS Reaffirms Their Buy Rating on Universal Health (UHS)

Ben Hendrix

RBC Capital

$183

Hold

6.48%

Upside

Reiterated

08/19/26

RBC Capital Sticks to Its Hold Rating for Universal Health (UHS)

Kevin Fischbeck

Bank of America Securities

$162→$170

Sell

-1.08%

Downside

Reiterated

08/10/26

Bank of America Securities Sticks to Their Sell Rating for Universal Health (UHS)

Scott Fidel

Goldman Sachs

$242→$190

Hold

10.56%

Upside

Assigned

07/30/26

Universal Health price target lowered to $190 from $242 at Goldman SachsUniversal Health price target lowered to $190 from $242 at Goldman Sachs

Craig Hettenbach

Morgan Stanley

$212→$191

Hold

11.14%

Upside

Reiterated

07/29/26

Analysts Conflicted on These Healthcare Names: Haemonetics (NYSE: HAE), Arrowhead Pharmaceuticals (NASDAQ: ARWR) and Universal Health (NYSE: UHS)

Ryan Langston

TD Cowen

$197

Buy

14.63%

Upside

Assigned

07/29/26

TD Cowen Reaffirms Their Buy Rating on Universal Health (UHS)

Michael Ha

Robert W. Baird

$204→$166

Hold

-3.41%

Downside

Reiterated

07/29/26

Universal Health price target lowered to $166 from $204 at BairdUniversal Health price target lowered to $166 from $204 at Baird

Sarah James

Cantor Fitzgerald

$194

Hold

12.88%

Upside

Reiterated

07/28/26

Analysts Offer Insights on Healthcare Companies: Universal Health (NYSE: UHS), Insmed (NASDAQ: INSM) and Edwards Lifesciences (NYSE: EW)

Jason Cassorla

Guggenheim

$195→$189

Buy

9.97%

Upside

Reiterated

07/28/26

Analysts Are Bullish on These Healthcare Stocks: Universal Health (UHS), Incyte (INCY)

Andrew Mok CFA

Barclays

$179→$168

Hold

-2.25%

Downside

Reiterated

07/28/26

Barclays Sticks to Its Hold Rating for Universal Health (UHS)

Ann Hynes

Mizuho Securities

$230→$200

Buy

16.37%

Upside

Reiterated

07/13/26

Mizuho Securities Sticks to Their Buy Rating for Universal Health (UHS)

John Ransom

Raymond James

―

Hold

―

Downgraded

04/29/26

Universal Health downgraded to Market Perform from Outperform at Raymond JamesUniversal Health downgraded to Market Perform from Outperform at Raymond James

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

10/28/25

KeyBanc Remains a Hold on Universal Health (UHS)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

JAZZJazz Pharmaceuticals

AXGNAxoGen

ARDXArdelyx

ARWRArrowhead Pharmaceuticals

PTGXProtagonist Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Universal Health

3 Months

Whit MayoLeerink Partners

Success Rate

21/31 ratings generated profit

Average Return

+4.51%

Copying Whit Mayo's trades and holding each position for 3 Months would result in 67.74% of your transactions generating a profit, with an average return of +4.51% per trade.

1 Year

Ann HynesMizuho Securities

Success Rate

20/27 ratings generated profit

Average Return

+11.15%

Copying Ann Hynes's trades and holding each position for 1 Year would result in 74.07% of your transactions generating a profit, with an average return of +11.15% per trade.

2 Years

Ann HynesMizuho Securities

Success Rate

21/27 ratings generated profit

Average Return

+23.83%

Copying Ann Hynes's trades and holding each position for 2 Years would result in 77.78% of your transactions generating a profit, with an average return of +23.83% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0LJL Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0LJL has received 7 Buy Ratings, 14 Hold Ratings, and 3 Sell Ratings. 0LJL average Analyst price target in the past 3 months is 192.62.

Each month's total comprises the sum of three months' worth of ratings.

0LJL Financial Forecast

0LJL Earnings Forecast

Next quarter’s earnings estimate for 0LJL is $5.23 with a range of $4.14 to $5.76. The previous quarter’s EPS was $5.98. 0LJL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0LJL has Performed in-line its overall industry.

0LJL Sales Forecast

Next quarter’s sales forecast for 0LJL is $4.72B with a range of $4.57B to $4.84B. The previous quarter’s sales results were $4.64B. 0LJL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0LJL has Performed in-line its overall industry.

0LJL Stock Forecast FAQ

What is GB:0LJL’s average 12-month price target, according to analysts?

Based on analyst ratings, Universal Health’s 12-month average price target is 192.62.

What is GB:0LJL’s upside potential, based on the analysts’ average price target?

Universal Health has 12.08% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Universal Health a Buy, Sell or Hold?

Universal Health has a consensus rating of Hold, which is based on 4 buy ratings, 8 hold ratings and 1 sell ratings.

What is Universal Health’s share price target?

The average share price target for Universal Health is 192.62. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $290.00 ,and the lowest forecast is $166.00. The average share price target represents 12.08% Increase from the current price of $171.86.

What do analysts say about Universal Health?

Universal Health’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of Universal Health?

To buy shares of GB:0LJL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Universal Health (0LJL) Share Forecast & Price Target

0LJL Analyst Ratings

0LJL Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Universal Health

0LJL Analyst Recommendation Trends

0LJL Financial Forecast

0LJL Earnings Forecast

0LJL Sales Forecast

0LJL Stock Forecast FAQ

Detailed List of Analyst Forecasts